CLOSE ×

Science and medicine are focused on understanding and solving the diseases of aging. With an aging population globally, we know that demand for your research in this area is expanding. Inotiv maintains a commercial inventory of male rat and female mouse models reserved monthly for aged animal availability, or can maintain cohorts of models upon request for your research needs.

Order today

+1 800 793 7287

Online order  

Technical Details

Inotiv provides ready availability of several rat and mouse models for your aged animal research. If the aged animals you need are not available from our inventory, or if the animals require three or more months of maintenance prior to shipment, Inotiv will reserve and hold specific cohorts of animals until the requested age at shipment.

Aged animals are appropriate for use in the following types of research:

  • Memory
  • Neoplasia
  • Longevity
  • Motor skills
  • Age-associated pathology
  • Neurobiology
  • Reproductive senescence
  • Osteoarthritis
  • Immune response
  • Vision and hearing
  • Renal degeneration
  • Metabolism
  • Cardiovascular

The following animal models are available for your aged animal research project:

Male rats:

Female mice:

Other models available for aging upon request, including C57BL/6NHsd mice.

Pricing

Pricing and availability of aged animals from the aging inventory is available on request. For client-reserved aging cohorts, pricing is developed based on the requirements of the project. Prior to initialization of an aging project, Inotiv will confirm your expectations, the project work scope, and animal pricing with an agreement of understanding.

INSIGHTS, Keep up-to-date with the latest industry thinking and scientific insights

SCIENTIFIC INSIGHTS

Keep up-to-date with the latest industry thinking and scientific insights

Explore today Explore today  
 ,  

More than 90 years of working together, to build a healthier and safer world  

 

Explore our history Explore our history  

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.

Subscribe now